The funding will support McMaster startups BiCova Therapeutics and PROVA Innovations as they develop and commercialize their health technologies.
Most people would prefer to die at home than in hospital. If dying at home could be made more feasible and well resourced, both the dying and the living would benefit.
Cameron Currie and his research team are studying a novel source of possible antimicrobial drugs: The bacteria that work with fungus-growing ants to protect their gardens from disease.
McMaster logo
McMaster logo
